Cell Therapeutics (CTIC) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cell Therapeutics (CTIC)

An SI Board Since August 1997

Posts	SubjectMarks	Bans	Symbol
946	45	0	CTIC

Emcee: Regis McConnell	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
571	<i>>>I bring up economics because paclitaxel is generic. Although CT	DewDiligence_on_SI	-	3/7/2005
570	Sam, sorry for any confusion..by deal breaker I was saying that if Xyotax indeed	zeta1961	-	3/7/2005
569	<i>>>That can easily happen if the two arms turn out not to be balan	DewDiligence_on_SI	-	3/7/2005
568	Zeta, I didn't mean to interrupt your conversation with former_pgs, but was	Sam Citron	-	3/7/2005
567	Sounds like, from the cc this morning, that Bianco and co. at least believe they	Rudy Saucillo	-	3/7/2005
566	<i> I don't understand how the Cox regression can be highly stat sig w	Biomaven	-	3/7/2005
565	<i>Why is this issue a "dealbreaker"?</i> Sam this is par	zeta1961	-	3/7/2005
564	<i>alopecia is a side effect that is underappreciated as an issue and imo,	Sam Citron	-	3/7/2005
563	Did they say how much less alopecia the xyvotox had? I once knew someone that	rkrw	-	3/7/2005
562	<If it was up to me I'd let the clinics decide the cost / benefit trade-o	zeta1961	-	3/7/2005
561	<i>>> Neither of these statements make a lot of sense to me. I don&#	DewDiligence_on_SI	-	3/7/2005
560	<<Normally the allocation to the two arms is completely randomized - the d	Clarksterh	-	3/7/2005
559	Unfortunately, Xyotax did not appear to appreciably reduce the incidence of bloo	former_pgs	-	3/7/2005
558	It's an interesting and relatively short call. Several times, during the ca	Ian@SI	-	3/7/2005
557	<i>found a way around the stratification</i> I didn't listen to	Biomaven	-	3/7/2005
556	Probably the most interesting items (to me) in the cc were: 1) The fact that th	Clarksterh	-	3/7/2005
555	I'm going to revisit the CC. Maybe I can pick something up that I missed in	mangery	-	3/7/2005
554	I didn't listen to the CC yet since I knew I was going to sell based on the	zeta1961	-	3/7/2005
553	Yes, he appeared to be rather subdued. But the circumstances were maybe not the	Icebrg	-	3/7/2005
552	<i>But, as we don't know how Xyotax fared from an efficacy point of vi	mangery	-	3/7/2005
551	<I bring up economics because paclitaxel is generic.> Has anyone here see	zeta1961	-	3/7/2005
550	First thing first. If approved the market will at least be large enough to make	Icebrg	-	3/7/2005
549	>It is not only a matter of alopecia. Not being based on Cremafore is another	former_pgs	-	3/7/2005
548	If CTI is able to prove to the satisfaction of FDA's statisticians, that the	Icebrg	-	3/7/2005
547	They will just change their let down day to Friday since you post that last post	manny_velasco	-	3/7/2005

Go to reply# or date (mm/dd/yy):